Introduction
============

Gastrointestinal (GI) nematode infections in ruminants remain a major impediment to the efficient production of both meat and dairy products, and therefore, represent a major constraint on global food availability. These GI infections have a significant economic impact on the U.S. cattle industry, with an estimated annual cost of \~\$2 billion per year in lost productivity and increased operating expenses. Nematode infections of the GI tract impact numerous production traits. Among the most prominent effect is a reduction in weight gain that may cause decreased bodyweights of up to 14% \[[@B1]\]. Although the impact is particularly evident in young calves, substantial evidence suggests that infection produces long lasting effects on the productivity of adult cattle \[[@B2]\]. In dairy cows, parasitic infections reduce milk yield between 1.2 and 2.2 kg milk/cow per day \[[@B3]\]. Infections also negatively impact carcass quality and reproductive performance, including calving rate and calf mortality \[[@B4]\]. Potential economic loss resulting from GI nematode infections is clearly recognized by producers and veterinarians, as evidenced by the fact that approximately 99% of feedlots and 69% of dairies use a parasiticide in their operations \[[@B5]\].

Among 41 bovine GI nematodes, species from the genera *Ostertagia*, *Cooperia*, and *Nematodirus*are arguably the most important cattle parasites in temperate regions of the world, as assessed by their negative economic impact \[[@B6]\]. Development of protective immunity and resistance to these GI nematodes relies upon the precise control of expression of the host genome. It is evident that the evolution of regulatory programs controlling the transcriptome occurs at a rapid rate comparable to that of other genomic processes. Understanding these regulatory elements is crucial towards unraveling their functional relevance. Comparative transcriptomic analysis has emerged as a promising means for unraveling the molecular basis and regulatory networks underlying complex traits such as host resistance. While recent progress has been made with regard to genes associated with nematode resistance in small ruminants \[[@B7]-[@B9]\], an in-depth comparison and characterization of transcriptomic responses of cattle populations that harbor varying degrees of resistance to parasitic nematodes is not yet available. Sequencing steady-state RNA in a biological sample (RNA-seq technology) using next-generation sequencing platforms (e.g. Illumina) overcomes many limitations of previous technologies, such as microarrays and real-time PCR. Most importantly, RNA-seq has been shown to elucidate previously inaccessible complexities in the transcriptome, such as allele-specific expression and involvement of novel promoters and isoforms \[[@B10]\], detection of alternative splicing \[[@B11]\], RNA editing \[[@B12]\], novel transcripts \[[@B13]\], all in conjunction with quantitative evaluation of transcript abundance \[[@B14]\]. In this study, we utilized RNA-seq technology to characterize the bovine transcriptome response of nematode-resistant and nematode-susceptible heifers to identify molecular mechanisms that underlie host resistance to GI nematodes in cattle.

Materials and methods
=====================

Animals and parasitology
------------------------

Six 12-month-old Angus heifers that differed with regard to susceptibility to GI nematode infection (3 resistant and 3 susceptible) were used in this experiment. These heifers were from a selective breeding program for parasite resistance that was initiated at our facilities in 1991, using parental stock originating from the Wye Angus herd \[[@B15],[@B16]\]. Once the initial breeding females were identified, semen from high and low EPG (eggs per gram of feces) bulls was used to produce calves of desired phenotypes. Calves were kept with their dams on pastures with extremely low numbers of parasites prior to weaning. When the median age of the contemporary group was 205 days, calves were weaned and placed on pastures infected with the two most common nematode parasites of cattle, *Ostertagiaostertagi*and *Cooperiaoncophora*. The calves were monitored weekly for a number of parasitologic and immunologic parameters along with selected measurements of animal growth. The calves were kept pastured for a minimum of 120 days. Replacement animals were selected for secondary challenge experiments, while parasitologic and immunologic parameters were collected from animals chosen for slaughter. This program resulted in resource populations selected for the fecal egg trait (high or low fecal eggs counts or eggs per gram, EPG; high or low parasite resistance, respectively). Based on actual weekly EPG counts and sire expected progeny difference (EPD) values for EPG, a total of six heifers were selected for this study. Three heifers used in this study were classified as susceptible (high EPG EPD value) and the remaining 3 were classified as resistant (low EPG EPD value).

At the end of the grazing season, all heifers were treated with a combination of 10 mg fenbendazole and 0.5 mg moxidectin per kg of body weight to remove existing GI parasites transmitted from the infected pastures. After resting for 30 days on concrete to preclude further parasite exposure, the heifers were orally infected with a single dose of combined *O. ostertagi*and *C. oncophora*infective L3 larvae (8.5 × 10^4^and 1.0 × 10^5^*O. ostertagi*and *C. oncophora*L3 larvae, respectively, per animal) and housed on concrete for an additional 20 days, allowing the experimental infection to progress. EPG was monitored during the resting period to ensure that the drug treatment eliminated all pre-existing parasites. The infective L3 larvae were obtained from cultures maintained at the USDA-ARS Beltsville facilities. The heifers were handled according to a protocol approved by the Beltsville Agricultural Research Center Animal Care and Use Committee, following Institutional Animal Care and Use Committees (IACUC) guidelines. The heifers were sacrificed at 20 days post infection (dpi). Worms were counted from the contents of the abomasum and small intestine. The full-thickness of folds from the fundic abomasa were collected, minced into 1-2 cm pieces, and snap frozen in liquid nitrogen prior to storage at -80°C until total RNA was extracted.

RNA extraction and sequencing using RNA-seq technology
------------------------------------------------------

Total RNA was extracted using Trizol followed by DNase digestion and Qiagen RNeasy column purification as previously described \[[@B17]\]. The RNA integrity was verified using an Agilent Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA) with a RIN value \> 7.0. High-quality RNA was processed using an Illumina RNA-seq sample prep kit following the manufacturer\'s instruction (Illumina, San Diego, CA, USA). Final RNA-seq libraries were validated and sequenced at 36bp/sequence read using an Illumina GAIIx sequencer at a depth of approximately 23.7 million sequences per sample (mean ± SD = 23 723 620 ± 7 447 499 per sample).

Data analysis and bioinformatics
--------------------------------

23 632 bovine genes in the Bovine Official Gene Set version 2 (OGS2.0) \[[@B18]\] were first mapped to the bovine reference genome (Btau4.0) using Genomic Short-read Nucleotide Alignment Program or GSNAP \[[@B19]\]. The best mapping position of each gene (≤ 10 kb intron span, ≥ 95% identity, ≥ 90% coverage, and minimum tail length of 5% of coding sequences) was extracted. Accordingly, 20 809 of the 23 632 bovine genes were uniquely mapped. After removing ambiguously mapped genes, 18 834 genes were used for RNA-seq data analysis.

Raw sequence reads were then checked using several layers of quality control filtering to remove low-quality reads. Raw reads with ≥ 2 ambiguous nucleotides (N) were discarded. Trimming removed approximately 1% of input raw reads and led to the retention of 99% of raw reads. The input reads after cleansing were mapped to the reference genome with gene coordinates using Bowtie (v0.12.7), an ultrafast and memory-efficient short-read aligner using a Burrows-Wheeler index \[[@B20]\]. Approximately 68.5% of trimmed reads mapped to the bovine genome (mean ± SD = 68.54% ± 2.48%). Only reads with one unique best match in the reference genome were used for subsequent analyses. The read depth of each gene was computed based on the coordinates of mapped reads and gene locations in the reference genome and was normalized using a method that corrects for biases introduced by RNA composition and differences in the total numbers of uniquely mapped reads in each sample \[[@B21]\]. Only genes having ≥ 20 uniquely mapped reads (mean of all 6 samples) were further analyzed. The R package *edgeR*was used to test the null hypothesis that expression of a given gene is not different between the two groups \[[@B21]\]. The normalized read counts were also analyzed using the DEGseq algorithm \[[@B22]\]. The DEGseq built-in function \"samWrapper\" that is recommended for testing RNA-seq data with biological replication was used to detect differential expression. Candidate genes were first sorted based on *P*value (*P*\< 0.05) and fold change (2-fold as a cutoff). Genes identified as candidates for differential expression were further filtered with a false discovery rate (FDR) of \< 5% to account for multiple testing. Differentially-expressed genes in the transcriptome were further analyzed using Gene Ontology (GO) analysis (GOseq). Over-representation of certain GO terms was determined based on Fisher\'s exact test. A multiple correction control (permutation to control false discovery rate \[[@B23]\]) was implemented to set up the threshold to obtain the lists of significantly over-represented GO terms. The candidate genes were analyzed using IPA v9.0 for pathways (Ingenuity Systems, Redwood City, CA, USA).

Tophat (v1.2.0) was used to map input reads to the reference genome \[[@B11]\] and identify potential splice junctions or splicing variants. Only reads with one unique match in the reference genome were used for subsequent analyses. The maximum allowed intron size was 5kb (a conservative parameter to avoid a high false discovery rate). At each potential splice junction, spanning reads were counted. Potential splice junctions were compared to annotated splice sites. To identify differential splice junctions between two groups, normalized read counts of splice junctions were required to be eight times different between resistant and susceptible groups. An unpaired *t*-test was performed on normalized sequence read counts. Splice junctions at *P*≤ 0.05 were considered candidates junctions that were differentially regulated between resistant and susceptible groups.

Real-time RT-PCR
----------------

Real-time or quantitative RT-PCR (qPCR) was performed as previously described \[[@B17]\]. Briefly, the cDNA synthesis was performed using an iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA). Real-time RT-PCR analysis was carried out with an iQ SYBR Green Supermix kit (Biorad) using 200 nM of each amplification primer and the 1^st^-strand cDNA (100 ng of the input total RNA equivalents) in a 25 μL reaction volume as described. The amplification was carried out on an iCycler iQ™ Real Time PCR Detection System (BioRad) with the following profile: 95°C-60 s; 40 cycles of 94°C-15 s, 60°C-30 s, and 72°C-30 s. A melting curve analysis was performed for each primer pair. The gene encoding for phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), which has a relatively constant expression level across all experiment samples, was used as an endogenous control. Relative gene expression data was calculated using the 2^-ΔΔCT^method. The fold change was normalized against the susceptible group.

Results
=======

EPG and worm counts
-------------------

Mean weekly EPG values were 8.8 ± 1.6 (Mean ± SD) and 31.3 ± 10.4 for low-EPG (resistant) and high-EPG (susceptible) heifers, respectively (*N*= 3) during the 6-month grazing season (Figure [1](#F1){ref-type="fig"}). In accordance with the experimental design, this difference was statistically significant (*P*\< 0.05). Although a temporal fluctuation in weekly EPG values was evident, resistant heifers shed constantly fewer parasite eggs in feces than did susceptible heifers. Over the grazing period, resistant heifers gained more weight (*P*\< 0.05) than susceptible heifers (159.0 ± 32.8 vs 92.1 ± 20.4 lbs). Similarly, resistant heifers displayed a numerically, but not statistically, greater (*P*\> 0.05) gain in hip height over the experiment period (Table [1](#T1){ref-type="table"}). Serum pepsinogen levels between both resistant and susceptible groups were statistically indistinguishable. The mean number of total parasite worms (both *O. ostertagi*and *C. oncophora*) recovered from resistant heifers (5 200 ± 3 191) after the experimental challenge were numerically less than those of susceptible heifers (5 923 ± 3 203), but not significantly less (*P*\> 0.05). These worm burden data were not unexpected because the population under study has never been selected for worm burdens as an indicator trait in the applied breeding program. Additionally, the worm counts were obtained from an experimental infection with a high dose of infective larvae that is not typically encountered by calves under nature exposure.

![**Weekly mean fecal egg counts (eggs per gram, EPG or FEC) of resistant and susceptible Angus heifers grazing on infected pasture between April to October**. Y-axis represents mean weekly fecal egg counts. \* indicates a significant difference in EPG between resistant and susceptible groups (*P*\< 0.05). \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.](1297-9716-42-114-1){#F1}

###### 

Growth and parasitology parameters between parasite-resistant or susceptible cattle.

                                        Resistant        Susceptible
  ------------------------------------- ---------------- ---------------
  [During grazing period:]{.ul}                          
   EPG (weekly mean)                    8.8 ± 1.6\*      31.3 ± 10.4
   Weight gain (lb)                     159.0 ± 32.8\*   92.1 ± 20.4
   Hip height gain (cM)                 8.26 ± 1.10      6.35 ± 2.54
   Pepsinogen (mU)                      689.0 ± 20.0     672.5 ± 230.0
  [Post experimental infection:]{.ul}                    
   Worm count                           5200 ± 3191      5923 ± 3203
                                                         
  Mean ± SD (*N*= 3)                                     
  \**P*\< 0.05                                           

General characteristics of the bovine abomasal transcriptome
------------------------------------------------------------

20 809 of the 23 633 bovine genes (88%) were uniquely mapped to the bovine genome (Bta4.0). Among these, 18 834 genes were unambiguously mapped and were used for RNA-seq analysis. 14 549 to 15 432 of the 18 834 genes had at least one copy of their transcripts expressed in the bovine abomasal transcriptome (61.6 to 65.3% of all bovine genes). 11 474 to 13 015 genes had ≥ 10 sequence hits in the bovine abomasal tissue. 13 758 genes were expressed in all bovine abomasal samples tested, probably representing the core component of the bovine abomasal transcriptome. The most abundant transcript in all 6 abomasal samples tested was a gene (Gene ID: BT14427) located on *Bos taurus*autosome (BTA or chromosome) 29 whose function is unknown but represents 10.38% of sequence reads in the transcriptome. The next most abundant transcripts included an unknown gene (BT10810, 2.36%), polymeric immunoglobulin receptor (PIGR, 1.60%), a gene on BTA11 (BT28533, 1.29%), complement C3 (0.73%), growth arrest-specific protein 7 (0.67%), pre-B lymphocyte protein 3 (0.60%), liver fatty acid-binding protein (0.56%), IgG Fc-binding protein (0.53%), and immunoglobulin J chain (0.49%). The 10 most abundant protein-coding genes accounted for 19.21% of all sequence reads in the bovine abomasal transcriptome.

Differentially expressed genes
------------------------------

Normalized sequence counts were analyzed using both *edgeR*and DEGseq algorithms. A total of 203 genes met 2 criteria: unadjusted *P*value \< 0.05 and 2-fold difference in normalized read counts between resistant and susceptible animals (Additional file [1](#S1){ref-type="supplementary-material"}). These candidate genes were further filtered with a stringent cutoff (FDR \< 5%). Sixty four genes were significantly different between resistant and susceptible animals at FDR \< 5% (Table [2](#T2){ref-type="table"}). These genes had a significantly higher ratio of normalized sequence counts between resistant and susceptible groups. For example, common salivary protein BSP10, form A (BT12506 or SPLUNC2A) was expressed 57.68 fold higher in resistant heifers. Similarly, the sequence counts of intelectin (ITLN2) in the abomasum of resistant heifers were 51.98 times higher than in that of susceptible heifers. Mucin 12 (MUC12) and fatty acid binding protein 6, ileal (FABP6, intestinal bile acid-binding protein or gastrotropin) were significantly over-expressed in resistant animals. Several apolipoproteins (APOA1, A4, B100, and C2) were also over-expressed in resistant heifers. Transcripts for alpha-inducible protein 27 and 27-like 2 (IFI27 and IFI27L2) were more abundant in resistant than in susceptible animals.

###### 

Genes significantly regulated during parasitic infections in resistant cattle.

  ID Symbol          BTA     Start       End         Ratio   P value FDR    Resistant RPKM      Susceptible RPKM
  ------------------ ------- ----------- ----------- ------- -------------- ------------------- ------------------
  BT23148 ACCN3      Chr4    117903455   117907312   12.73   0.000 0.0000   3.97 ± 6.61         0.27 ± 0.06
  BT15243 ANPEP      Chr21   20951416    20967921    11.08   0.000 0.0000   40.93 ± 28.64       3.67 ± 0.80
  BT22521 APOA1      Chr15   25933779    25935362    5.98    0.000 0.0000   5360.53 ± 1986.27   895.53 ± 533.24
  BT12506 SPLUNC2A   Chr13   63394161    63402279    57.68   0.000 0.0000   4.80 ± 6.20         0.10 ± 0.10
  BT25183 CSMD2      Chr3    118882335   119566628   9.58    0.000 0.0000   1.23 ± 0.65         0.13 ± 0.06
  BT22188 CYP4B1     Chr3    106240610   106260595   7.21    0.000 0.0000   4.67 ± 1.85         0.63 ± 0.15
  BT26217 DUOX2      Chr10   66934451    66952107    12.47   0.000 0.0000   10.27 ± 14.53       0.87 ± 0.55
  BT27848 FABP6      Chr7    71616618    71622552    8.34    0.000 0.0000   20.10 ± 29.36       2.23 ± 0.45
  BT22964 ITLN2      Chr3    9558554     9565419     51.98   0.000 0.0000   18.37 ± 29.41       0.37 ± 0.47
  BT19368            Chr25   4742693     4775217     6.96    0.000 0.0000   82.73 ± 63.48       11.77 ± 8.64
  BT10244 PRSS2      Chr4    110025504   110029213   57.68   0.000 0.0000   17.93 ± 30.63       0.37 ± 0.23
  BT28349 SLC6A18    Chr20   75154396    75168950    8.28    0.000 0.0000   18.87 ± 13.67       2.27 ± 0.70
  BT11110            Chr13   59373661    59378915    5.86    0.000 0.0000   36.77 ± 10.25       6.30 ± 1.87
  BT18264            Chr2    124281340   124288387   8.94    0.000 0.0000   2.87 ± 2.00         0.33 ± 0.12
  BT26677 MRP4       ChrUn   841         156276      8.00    0.000 0.0000   12.37 ± 11.34       1.50 ± 0.78
  BT29561            Chr10   66930244    66933576    22.63   0.000 0.0000   17.40 ± 27.38       0.83 ± 0.49
  BT16567 APOA4      Chr15   25908269    25910771    4.44    0.000 0.0000   2075.70 ± 1258.45   466.47 ± 179.94
  BT20816 APOC3      Chr15   25916846    25918590    4.59    0.000 0.0000   1467.53 ± 591.47    319.20 ± 105.66
  BT20772            Chr6    87416154    87458606    5.54    0.000 0.0000   6.30 ± 5.07         1.13 ± 0.32
  BT16522 MS4A10     Chr29   38877233    38884049    4.79    0.000 0.0000   75.00 ± 16.71       15.73 ± 4.97
  BT13412 APOB       Chr11   80208992    80221450    4.41    0.000 0.0000   166.77 ± 21.11      37.80 ± 13.65
  BT25015 ISG15      Chr16   48718864    48719323    4.47    0.000 0.0000   61.67 ± 35.27       13.63 ± 6.02
  BT13211            Chr2    124265402   124268318   4.14    0.000 0.0001   149.53 ± 65.38      36.03 ± 13.41
  BT26247 MAPK11     ChrUn   21657       24311       4.11    0.000 0.0001   37.87 ± 24.23       9.03 ± 4.17
  BT16178            Chr23   17665934    17668511    5.06    0.000 0.0001   6.90 ± 3.24         1.30 ± 0.36
  BT10335 CD36       ChrUn   11614       40612       3.97    0.000 0.0001   78.23 ± 52.91       19.73 ± 4.58
  BT29523            Chr28   1263980     1431674     4.56    0.000 0.0002   3.07 ± 0.38         0.67 ± 0.64
  BT30176 AKR1C3     Chr13   43830404    43853848    4.23    0.000 0.0002   14.237 ± .61        3.40 ± 0.26
  BT16664            ChrX    70843101    71124091    5.28    0.000 0.0003   4.87 ± 5.93         1.03 ± 0.86
  BT21051            Chr26   16748567    16803178    3.76    0.000 0.0004   26.30 ± 9.04        6.97 ± 1.55
  BT28260            Chr16   48526316    48530064    4.26    0.000 0.0006   7.43 ± 2.64         1.67 ± 0.72
  BT10100 KLRJ1      Chr5    106747081   106756866   3.68    0.000 0.0009   16.73 ± 6.80        4.37 ± 2.66
  BT23076 HABP2      Chr26   34481504    34515729    3.84    0.000 0.0009   6.30 ± 4.06         1.57 ± 0.71
  BT14255 RHOD       Chr29   46952791    46962446    3.92    0.000 0.0009   18.20 ± 13.04       4.67 ± 1.69
  BT27136 MUC12      Chr25   37794638    37851653    3.41    0.000 0.0014   651.97 ± 214.37     191.10 ± 21.35
  BT25367 TMEM151A   Chr29   46232359    46233687    4.11    0.000 0.0015   3.80 ± 3.18         0.83 ± 0.40
  BT22967 LAMB3      Chr16   71833965    71874951    3.39    0.000 0.0016   18.07 ± 7.98        5.30 ± 1.35
  BT18107            ChrUn   25167       25761       3.39    0.000 0.0016   54.57 ± 39.67       15.50 ± 23.47
  BT22962 PMP22      Chr19   33646745    33669580    3.29    0.000 0.0031   70.67 ± 30.81       21.30 ± 3.36
  BT12589            Chr26   9064853     9107531     3.23    0.000 0.0042   21.07 ± 11.38       6.50 ± 3.35
  BT20448 STYK1      Chr5    106284244   106301611   3.41    0.000 0.0052   7.07 ± 2.12         1.97 ± 0.83
  BT27305 CR2        ChrUn   83330       107409      3.66    0.000 0.0061   3.00 ± 2.87         0.77 ± 0.15
  BT23649 UBD        Chr23   29024538    29026285    3.14    0.000 0.0063   48.37 ± 31.81       14.97 ± 7.41
  BT21042 CLCA4      Chr3    61006123    61036756    3.03    0.000 0.0067   89.97 ± 36.33       29.57 ± 21.61
  BT16585 GDPD2      ChrX    49832662    49839846    3.07    0.000 0.0071   32.20 ± 3.57        10.43 ± 1.76
  BT18095 IFI27      Chr21   59045145    59052921    2.99    0.000 0.0092   109.67 ± 95.80      36.37 ± 13.02
  BT23509 RSAD2      Chr11   92861557    92877381    3.20    0.000 0.0104   10.27 ± 3.46        3.17 ± 0.99
  BT17415 TMEM37     Chr2    74700175    74705806    4.20    0.000 0.0107   5.53 ± 3.86         1.30 ± 0.66
  BT22660 SLC7A8     Chr10   21975064    22025425    3.20    0.000 0.0119   6.20 ± 1.61         1.93 ± 0.35
  BT29929            Chr10   35876816    35888464    2.91    0.000 0.0128   214.37 ± 116.87     73.60 ± 3.59
  BT23760 IFI27L2    Chr21   59033630    59035497    2.95    0.000 0.0136   161.83 ± 67.72      55.17 ± 21.09
  BT29480 APOC2      Chr18   52441529    52442339    3.66    0.000 0.0152   15.27 ± 8.78        4.43 ± 1.44
  BT14554            Chr19   49340980    49341417    2.89    0.000 0.0263   38.03 ± 26.47       12.97 ± 4.14
  BT26136 RCAN1      Chr1    327957      337475      3.05    0.000 0.0265   16.73 ± 4.79        5.60 ± 2.16
  BT30154 FLVCR2     Chr10   89235896    89375608    2.87    0.000 0.0309   7.97 ± 1.66         2.73 ± 0.68
  BT14279 ACE        Chr19   49341698    49380229    2.71    0.000 0.0315   55.47 ± 25.96       20.50 ± 4.80
  BT10643 TRPV6      Chr4    110136393   110152623   3.18    0.000 0.0330   3.73 ± 1.35         1.30 ± 0.95
  BT22748 SAMD9      Chr4    10706910    10711652    2.75    0.000 0.0396   5.33 ± 3.53         1.93 ± 0.15
  BT24262 BoLA       Chr23   27786581    27806088    2.69    0.000 0.0407   59.40 ± 56.51       21.70 ± 7.07
  BT12279 CYP3A4     ChrUn   25739       84849       2.71    0.000 0.0407   13.80 ± 5.60        5.00 ± 2.23
  BT14013            Chr2    124213765   124262789   3.25    0.000 0.0407   1.83 ± 1.33         0.57 ± 0.23
  BT13301 SECTM1     Chr19   51927819    51929433    2.73    0.000 0.0408   34.83 ± 22.23       12.57 ± 6.56
  BT20562 UNC13C     Chr10   56622366    57047991    2.93    0.000 0.0461   2.47 ± 3.58         0.90 ± 0.20
  BT17441 GGT1       Chr17   74684303    74693673    2.62    0.000 0.0473   35.97 ± 21.37       13.60 ± 5.19

64 of 203 differentially expressed genes at a false discovery rate FDR \<5% are listed.

The numbers denote mean ± SD (N = 3). Ratio = normalized read counts of resistant animals divided by normalized read counts of susceptible animals. RPKM = reads per kilobase of exon model per million mapped reads. BTA = Bos taurus autosome (chromosome).

\*Read count ratio = normalized read counts of resistant animals (Low-EPG) divided by normalized read counts of susceptible animals (High-EPG). \*\*mean ± SD. RPKM = reads per kilobase of exon model per million mapped reads \[[@B14]\].

BTA = *Bos taurus*autosome (chromosome).

Splicing variants
-----------------

A total of 94 224 potential splice junctions spanned by ≥ 1 sequence read were identified using TopHat. Among them, 139 junctions displayed a significantly different number of sequence reads between resistant and susceptible groups (FDR \< 5%). These 139 junctions were distributed on 28 autosomes and the X chromosome. There were no junctions on BTA12 that had significantly different numbers of sequence reads between the two groups. However, the distribution of these 139 junctions did not appear to be random, and the number of these junctions was not proportional to the physical length of the chromosomes. The vast majority of these junctions were unique to one of the two groups. For example, 90 of the 139 junctions were observed in all 3 resistant heifers but absent in 3 susceptible heifers. On the other hand, 43 were only present in susceptible heifers. Some of these unique junctions were observed in 9 of the 64 differentially expressed genes. For instance, 8 sequences (normalized mean counts) spanning an intron-exon junction (Intron position start 33 668 350 and end 33 669 502) on BTA19 were observed only in susceptible heifers and occurred inside a gene named peripheral myelin protein 2 (BT22962). A unique junction in the gene GDPD2 (BT16585) was observed only in resistant animals. The 10 most abundant unique junctions from each group are listed in Table [3](#T3){ref-type="table"}.

###### 

Select unique splice junctions.

  GeneID    Symbol    BTA     Intron start   Intron end   Strand   P      Resistant RPKM   Susceptible RPKM
  --------- --------- ------- -------------- ------------ -------- ------ ---------------- ------------------
  BT19086   RPLP0     17      65831745       65832562     \-       0.00   191.67 ± 52.35   0.00 ± 0.00
                      22      57847411       57847968     \+       0.02   95.67 ± 40.62    0.00 ± 0.00
  BT30349             25      15202695       15206251     \-       0.01   65.33 ± 25.11    0.00 ± 0.00
  BT16030             18      45802227       45803786     \+       0.00   61.00 ± 14.00    0.00 ± 0.00
  BT30349             25      15211963       15213263     \-       0.02   41.67 ± 18.01    0.00 ± 0.00
  BT16075   PDIA4     4       1.17E+08       1.17E+08     \-       0.00   34.67 ± 2.89     0.00 ± 0.00
  BT11599   CDH1      18      35125197       35126364     \+       0.00   28.33 ± 8.08     0.00 ± 0.00
  BT21452   NDUFS8    29      47590889       47590971     \-       0.03   28.00 ± 14.53    0.00 ± 0.00
  BT10815             18      56111950       56112091     \+       0.02   25.33 ± 11.72    0.00 ± 0.00
  BT16221   CAPRIN1   15      64405872       64406267     \+       0.00   25.33 ± 3.21     0.00 ± 0.00
  BT18538   MGST3     3       3966963        3968087      \-       0.00   0.00 ± 0.00      152.00 ± 22.54
  BT11164   ATP1A1    3       29338231       29338761     \-       0.02   0.00 ± 0.00      143.00 ± 65.80
  BT17219             7       18630456       18631070     \+       0.00   0.00 ± 0.00      78.67 ± 11.50
  BT24099             7       9449807        9451903      \+       0.00   0.00 ± 0.00      62.67 ± 15.53
  BT10200   TPI1      5       10565021       10565403     \-       0.00   0.00 ± 0.00      55.67 ± 15.89
  BT23745   ATP5O     1       725492         726173       \+       0.01   0.00 ± 0.00      46.67 ± 15.63
  BT10027   STOM      8       1.16E+08       1.16E+08     \-       0.00   0.00 ± 0.00      46.33 ± 6.43
  BT23715   IDH2      un004   22811          25159        \+       0.00   0.00 ± 0.00      43.67 ± 9.07
  BT13211             2       1.24E+08       1.24E+08     \+       0.01   0.00 ± 0.00      41.00 ± 17.09
  BT16976             5       1.17E+08       1.17E+08     \-       0.00   0.00 ± 0.00      40.67 ± 10.50

BTA = *Bos taurus*autosome (chromosome). RPKM = reads per kilobase of exon model per million mapped reads (mean ± SD).

Gene Ontology (GO) and pathway analyses
---------------------------------------

Over-representation of GO terms was determined based on Fisher\'s exact test and filtered further using a multiple correction control at FDR \< 5%. As Table [4](#T4){ref-type="table"} shows, the GO enrichment of genes under study was predominantly associated with lipid metabolism.

###### 

Gene Ontology (GO) associated with 64 genes that are differentially expressed.

  GO ID        GO Description                               Gene\#   P value    FDR
  ------------ -------------------------------------------- -------- ---------- ------
  GO:0042632   cholesterol homeostasis                      4        1.58E-05   0.01
  GO:0030301   cholesterol transport                        5        3.93E-07   0.00
  GO:0017127   cholesterol transporter activity             3        1.32E-05   0.01
  GO:0042627   chylomicron                                  3        5.56E-06   0.00
  GO:0005615   extracellular space                          9        3.23E-05   0.05
  GO:0034364   high-density lipoprotein particle            3        8.85E-06   0.01
  GO:0006869   lipid transport                              6        1.04E-05   0.01
  GO:0042157   lipoprotein metabolic process                4        8.31E-06   0.01
  GO:0042953   lipoprotein transport                        3        3.19E-06   0.00
  GO:0034367   macromolecular complex remodeling            4        1.11E-06   0.00
  GO:0044243   multicellular organismal catabolic process   3        3.42E-05   0.05
  GO:0071702   organic substance transport                  9        5.81E-06   0.01
  GO:0033700   phospholipid efflux                          3        3.19E-06   0.00
  GO:0034358   plasma lipoprotein particle                  4        1.11E-06   0.00
  GO:0034377   plasma lipoprotein particle assembly         3        8.85E-06   0.01
  GO:0034381   plasma lipoprotein particle clearance        4        2.73E-07   0.00
  GO:0071827   plasma lipoprotein particle organization     4        2.45E-06   0.00
  GO:0034369   plasma lipoprotein particle remodeling       4        1.11E-06   0.00
  GO:0005886   plasma membrane                              20       3.44E-05   0.05
  GO:0032994   protein-lipid complex                        4        1.11E-06   0.00
  GO:0065005   protein-lipid complex assembly               3        8.85E-06   0.01
  GO:0034368   protein-lipid complex remodeling             4        1.11E-06   0.00
  GO:0071825   protein-lipid complex subunit organization   4        2.45E-06   0.00
  GO:0032374   regulation of cholesterol transport          3        4.43E-05   0.06
  GO:0032371   regulation of sterol transport               3        4.43E-05   0.06
  GO:0010901   regulation of VLDL particle remodeling       2        3.01E-05   0.02
  GO:0043691   reverse cholesterol transport                3        4.43E-05   0.06
  GO:0055092   sterol homeostasis                           4        1.58E-05   0.01
  GO:0015918   sterol transport                             5        3.93E-07   0.00
  GO:0015248   sterol transporter activity                  4        1.88E-05   0.01
  GO:0005215   transporter activity                         12       1.38E-05   0.01
  GO:0034385   triglyceride-rich lipoprotein particle       4        1.74E-07   0.00
  GO:0034361   VLDL particle                                4        1.74E-07   0.00

VLDL = very low density lipoprotein. Gene\# = the number of significant genes that are associated with this GO process.

To gain insights into pathways involved in the development of parasite resistance, we analyzed the differentially expressed genes using Ingenuity pathways analysis software, IPA. Among the 7 regulatory networks identified (data not shown), the primary function of 3 networks was related to lipid metabolism. The primary function of the 3^rd^regulatory network was involved in antimicrobial response and inflammation. A total of 12 pathways were significantly impacted (*P*\< 0.05) and possibly involved in the development of host resistance to parasitic infection in cattle (Table [5](#T5){ref-type="table"}). FXR/RXR activation was the pathway most significantly impacted in resistant heifers (*P*= 3.66E-07) with at least 8 of the 203 differently expressed genes involved, including APOA1, APOB, APOC2, APOC3, FABP6, and IL18. The other pathways significantly impacted in resistant animals during parasitic infection included LXR/RXR activation (*P*= 2.78E-04), LPS/IL-1 mediated inhibition of RXR function (*P*= 8.80E-04), and arachidonic acid metabolism (*P*= 4.68E-03). In addition, acute phase response signaling was also impacted in resistant heifers (*P*\< 0.05).

###### 

Pathways significantly impacted during parasitic infection in resistant cattle.

  Pathways                                       P value    Genes impacted
  ---------------------------------------------- ---------- -------------------------------------------------------
  FXR/RXR Activation                             3.66E-07   ABCC2, IL18, APOB, SCARB1, FABP6, APOC3, APOA1, APOC2
  LXR/RXR Activation                             2.78E-04   IL18, APOA4, APOA1, CD36, APOC2
  LPS/IL-1 Mediated Inhibition of RXR Function   8.80E-04   ABCC2, SCARB1, FABP6, CYP3A4, APOC2, FMO5, SULT1B1
  Arachidonic Acid Metabolism                    4.68E-03   CYP4F2, AKR1C3, CYP3A4, CYP4B1, GGT1
  Nicotinate and Nicotinamide Metabolism         7.08E-03   ENPP3, VNN1, NT5E, BST1
  T Helper Cell Differentiation                  1.56E-02   IL18, IL21R, CXCR5
  Xenobiotic Metabolism Signaling                2.19E-02   ABCC2, CYP3A4, PPP2R2C, FMO5, MAPK11, SULT1B1
  Inhibition of Angiogenesis by TSP1             2.45E-02   CD36, MAPK11
  Interferon Signaling                           2.74E-02   OAS1, MX1
  Cell Cycle Regulation by BTG Family Proteins   2.89E-02   CCNE2, PPP2R2C
  Pyrimidine Metabolism                          3.05E-02   ENPP3, NT5E, ENTPD5, CTPS2
  Acute Phase Response Signaling                 4.21E-02   IL18, APOA1, RBP2, MAPK11

Real-time RT- PCR confirmation
------------------------------

The expression of 10 genes at mRNA level in the fundic abomasum was examined using real-time RT-PCR. The mRNA level of cholecystokinin B receptor (CCKBR, NM_174262), a receptor for gastrin, was extremely low in the fundic abomasum. The mRNA levels of gastrin (GAST, NM_173915) and pepsinogen 5, group I (pepsinogen A) (PGA5, NM_001001600) were reliably detected. PGA5 expression level appeared to be higher in resistant animals. However, the difference was not statistically significant due to a large variation while no changes in gastrin mRNA level between susceptible and resistant animals were detected. The expression of MUC12 was barely detectable (≤ 40Ct). The mRNA levels of glucosaminyl (N-acetyl) transferase 3, mucin type (GCNT3, NM_205809), mucin 2 (MUC2, NM_001245997), and galectin 15-like (LGALS13, XM_593263) were moderately abundant but no differences were detected between susceptible and resistant animals, consistent with the RNAseq results.

Expression levels of BPI fold containing family A, member 2A (BPIFA2A or SPUNC2A, NM_174803), bovine putative ISG12(a) protein (IFI27, NM_001038050), lectin, galactoside-binding, soluble, 3 (LGALS3, NM_001102341), and bovine collectin-46 (CL46, NM_001001856), were significantly higher in resistant animals, consistent with RNAseq data (Figure [2](#F2){ref-type="fig"}).

![**The expression profiles of SPUNC2A, LGALS3, IFI27, and CL46 in the bovine fundic abomasum of susceptible and resistant heifers**. The expression value at the mRNA level was detected using quantitative RT-PCR. The expression value of one of the susceptible animals was set as 1.0. The fold change as calculated using the 2^-ΔΔCT^method and normalized against the susceptible group (mean ± SD). SPUNC2A = BPI fold containing family A, member 2A (NM_174803); IFI27 = bovine putative ISG12(a) protein (NM_001038050); LGALS3 = lectin, galactoside-binding, soluble, 3 (NM_001102341), and CL46 = bovine collectin-46 (NM_001001856).](1297-9716-42-114-2){#F2}

Discussion
==========

The parameters of resistance to GI nematode infections in cattle while yet to be precisely defined, generally include decreased worm establishment and reduced parasite fecundity. It has long been known that host genetic factors play a significant role in determining susceptibility and resistance. Among eight factors determining EPG variation, additive genetic variation is predominant and accounts for \~30% of the variation in EPG \[[@B24]\]. Estimates of heritability for parasite indicator traits in ruminants are phenotype-dependent. In small ruminants, the heritability of adult worm length at the end of the first grazing season is very strong at 0.62 \[[@B24]\], whereas the heritability of EPG is moderate, ranging from 0.14 to 0.33 in Creole goats \[[@B25]\]. In cattle, the heritability of EPG released during the 1^st^grazing season is approximately 0.30 \[[@B26]\]. The ability of calves to recognize parasitic antigens is also under the control of host genetics \[[@B27]\]. Several studies suggest that there exist significant differences in the ability of cattle to resist GI nematode infections, and 3 major responder types can be readily identified in outbreed cattle populations \[[@B28],[@B29]\]. Worm establishment (worm burden) is predominantly influenced by host responder types. The ability of intermediate and high responders to mount a more effective and rapid immune response compared to low responders is sustained after secondary infection, providing more evidence that genetics may play an important role in regulating host resistance. The finding that the different responder types, based on parasitological variables, also feature a different immune response is very interesting since this also provides the opportunity to study the influence of genetic components of the host immune response \[[@B28]\]. These observations have spurred efforts to develop resource populations and identify genes and QTL that underlie the resistance trait and to develop criteria for selective breeding \[[@B30]\].

A vigorous and effective mucosal immunity is essential for resistance to GI nematode infection in ruminants. The resistant phenotype is often manifested in the host transcriptome. For example, resistant sheep breeds are able to more rapidly up-regulate Th2 cytokines than susceptible breeds \[[@B31]\]. In Angus cattle, our evidence suggests that resistant heifers can better maintain inflammatory responses at the sites of infection, especially during early stages of infection \[[@B16]\]. In the current study, we conducted an in-depth transcriptomic analysis to identify molecular mechanisms that underlie the development of host resistance in cattle, taking advantage of a resource population developed via selective breeding. Our results suggest that among the 94 224 splice junctions identified, 133 were uniquely present in either resistant or susceptible cattle, possibly representing novel splicing variants that have implications in the development of host resistance. We identified 203 candidate genes that displayed significantly different numbers of sequences between resistant and susceptible animals at a combined cutoff value *P*\< 0.05 and 2-fold.

The transcripts from 16 genes, including gastrin-releasing peptide (GRP) and macrophage-stimulating 1 (MST1), had a significantly higher number of sequences in susceptible cattle. GRP has been reported to be down-regulated by parasitic infection in a helminth-mouse system. Our results suggest that parasitic infection in susceptible cattle may have a negative impact on the host enteric nervous system that extends beyond its role in modulating normal functions of host epithelial, immune, and muscle cells \[[@B32]\].

Among the 187 genes with more abundant transcripts in the abomasum of resistant heifers, a notable feature was the up-regulation of various lectins. At least 4 lectins, such as bovine-specific collectin 46 (CL-46), C-type lectin domain family 12 member A (CLEC12A), galectin 3 (LGALS3), and intelectin 2 (ITLN2), had significantly more abundant transcripts in the abomasum of resistant cattle, which confirmed our previous study utilizing high-density DNA oligo arrays \[[@B33]\]. ITLN2 and several C-type lectins, such as collectin 11 (COLEC11), cattle-specific collectin-46, and conglutinin, as well as galectins were strongly up-regulated in the abomasal mucosa of immune cattle developed using multiple rounds of drug-attenuated infections \[[@B6],[@B33]\]. ITLN2 expression is regulated by Th2 cytokine IL-4 \[[@B34]\]. Its elevated expression is observed in the sheep abomasums in response to *Teladorsagia circumcincta*infection, *Dictyocaulus filaria*natural infection \[[@B35]\], and *Haemonchus contortus*infection \[[@B36]\]. Most pertinent, this gene is naturally deleted in the genome of the susceptible mouse strain, C57BL/10, but is present in the genome of a nematode-resistant mouse strain, BALB/c, suggesting that this gene may serve a protective role in the innate immune response to *Trichinella*infection \[[@B37]\]. Cattle-specific collectin-46 has been suggested to provide the first line of defense against pathogens without eliciting a general inflammatory reaction \[[@B38]\]. Galectins also play an important role in innate immunity, including serving as receptors for pathogen-associated molecule patterns (PAMP), which is integral in recognizing carbohydrate moieties on the cell surface of parasites, activating various immune cells, participating in cytotoxicity, modulating innate immunity via binding to IgA, and promoting the reconstruction of damaged tissues as receptors for damage-associated molecular patterns (DAMP) \[[@B39]\]. Together, our results suggest that lectins may play an important role in invoking effective host immune responses and in the development of host resistance.

Our evidence also indicates that alterations in lipid metabolism may be necessary to the development of host resistance. The top function of 3 of the 7 regulatory networks identified was associated with lipid metabolism. GO terms associated with genes that were differently expressed between resistant and susceptible animals were also predominantly related to lipid metabolism (Table [4](#T4){ref-type="table"}). Lipid metabolism is significantly regulated in the bovine small intestine. In response to *C. oncophora*infection, lipid balance in the GI tract during parasitic infection may be disrupted \[[@B17]\]. Polyunsaturated fatty acids (PUFA), especially those in omega-3 (n-3) and omega-6 (n-6) families, such as arachidonic acid and linoleic acid, have long been known to have strong immunomodulatory effects \[[@B40]\] and may serve as a potent inhibitor for Th1 response. In cattle, dietary supplementation with fish oil (omega-3 PUFA) results in a 24% reduction in EPG in calves that are infected with *O. ostertagi*and *C. oncophora*\[[@B41]\]. The treatment also leads to an increased percentage of immature parasites, indicating that PUFA may enhance protective immunity against parasitic infections. Interestingly, arachidonic acid metabolism was among the pathways most significantly impacted in resistant animals (Table [5](#T5){ref-type="table"}). Arachidonic acid (AA) is one of the important PUFA-associated membrane phospholipids. When liberated from the plasma membrane, AA can be oxidized, via a series of enzymatic steps, to a variety of eicosanoids, including prostaglandins, thromboxanes, prostacycline, and leukotrienes. Eicosanoids act as signaling molecules and stimulate a variety of responses in their target cells, such as innate immune responses \[[@B42]\], inflammation, and smooth-muscle contraction. Dietary n-3 PUFA has been used to attenuate tissue AA levels and subsequent eicosanoid formation. Recently, worm killing activities of AA have been demonstrated \[[@B43]\]. In mice, a single oral dose of AA led to a significant reduction of total worm burden of *Schistosoma*. AA-mediated parasite killing is suggested to be due to excessive activation of parasite neutral sphingomyelinase, leading to sphingomyelin hydrolysis into ceramide and phosphorylcholine \[[@B43]\]. In addition, products of the 5-lipoxygenase pathway, a part of AA metabolism, are important mediators of inflammation. 5-lipoxygenase plays a major role in controlling parasite burden of *Trypanosoma cruzi*in mice \[[@B44]\]. Detailed link between lipid metabolism and the development of protective immunity and host resistance to parasitic infections in cattle is worthy of further investigation.

The three most significant pathways impacted in resistant animals are associated with retinoid X receptor (RXR). These pathways included FXR/RXR activation, LXR/RXR activation, and LPS/IL-1 mediated inhibition of RXR functions. RXR acts as a master coordinator of numerous signaling pathways \[[@B45]\] via dimerizing with other nuclear receptors, such as liver X receptor (LXR), farnesoid X receptor (FXR), and vitamin D receptor (VDR). This partnership exerts transcriptional control and leads to distinct functions ranging from cell proliferation and differentiation to lipid metabolism. In addition, RXR can bind to a variety of natural and synthetic ligands, including omega-3 unsaturated fatty acids \[[@B45]\], which in turn stimulate transcriptional activation by RXR partners. While retinoic acid receptors (RAR) bind all-*trans*retinoic acid (RA) and its 9-*cis*isomer (9-*cis*RA), which convey most of the activity of RA, only 9-*cis*RA and docosahexaenoic acid (DHA) are suggested to be endogenous RXR ligands \[[@B46]\]. RA can inhibit cytokine expression including reduction of TNFα, iNOS, IL-6, and IL-1β at the mRNA level \[[@B47]\]. Recently, it has been observed that LPS-specific regulatory networks in which NF-κB plays a critical role in the mouse mucosa overlap with the LPS/IL-1β mediated inhibition of RXR functions \[[@B48]\]. The importance of RXR in cattle during *C. oncophora*infection has also recently been recognized \[[@B17]\]. Our future work will focus on the mechanistic link between RXR-related signaling pathways and the development of host resistance to GI nematode infection in cattle.
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###### Additional file 1

**Genes with significantly different read counts between resistant and susceptible cattle in response to parasitic infection**. A total of 203 genes met 2 criteria: unadjusted *P*value \< 0.05 and 2-fold difference in normalized read counts between resistant and susceptible animals.
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